Aster DM Healthcare Limited — PPTs, 05-02-2026: Investor Presentation

The combined Aster DM and Quality Care entity is now a top-3 hospital chain in India. The latest quarter saw revenue grow 15% year-on-year to INR 2,366 Cr, with operating EBITDA up 22% to INR 503 Cr (21.3% margin). Patient volumes increased 9%, reflecting strong performance.

The merger is expected to boost earnings and unlock 10-15% EBITDA upside from synergies. Strategic focus includes expanding bed capacity to over 14,710 beds via new projects, optimizing existing facilities, and digital health investments for patient reach.

The merger transaction is advancing, creating a diversified platform. Over the past year, the combined entity added over 560 beds, with multiple greenfield and brownfield expansions actively underway for future growth.

For the recent nine-month period, combined revenue hit INR 6,913 Cr (+13% YoY) and operating EBITDA reached INR 1,496 Cr (+20% YoY). Return on Capital Employed (RoCE) is 20.7%, with net debt at INR 329 Cr.

Management emphasizes consistent robust performance and a clear capital allocation strategy. They anticipate accelerated growth through strategic expansions and operational efficiencies.